Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
PUT
BioMarin Pharmaceuticals
BMRN
$11.9B
| $17.4M | 0.01% |
+197,000
| New | +$16.3M |
|
1002
Fidelity National Financial
FNF
$14.1B
| $17.4M | 0.01% |
346,309
-140,926
| -29% | -$6.74M |
|
1003
Murphy USA
MUSA
$9.9B
| $17.3M | 0.01% |
86,886
+53,724
| +162% | +$9.6M |
|
|
COHR
1004
DELISTED
Coherent Inc
COHR
| $17.3M | 0.01% |
64,849
+13,336
| +26% | +$3.44M |
|
1005
Interactive Brokers
IBKR
$38.8B
| $17.2M | 0.01% |
867,608
-356,360
| -29% | -$6.63M |
|
|
BAND
1006
Bandwidth Inc
BAND
$1.44B
| $17.1M | 0.01% |
238,485
+33,516
| +16% | +$2.61M |
|
1007
Saia
SAIA
$9.65B
| $17.1M | 0.01% |
50,674
+17,355
| +52% | +$5.39M |
|
|
EXAS
1008
DELISTED
Exact Sciences
EXAS
| $17.1M | 0.01% |
219,326
-5,369
| -2% | -$474K |
|
1009
Macerich
MAC
$6.66B
| $17M | 0.01% |
986,248
+155,592
| +19% | +$2.91M |
|
1010
Chegg
CHGG
$98.4M
| $17M | 0.01% |
554,624
+181,535
| +49% | +$7.36M |
|
1011
Syndax Pharmaceuticals
SNDX
$1.76B
| $17M | 0.01% |
775,476
+373,088
| +93% | +$6.89M |
|
1012
CALL
Albemarle
ALB
$14.8B
| $17M | 0.01% |
72,600
+43,400
| +149% | +$10.7M |
|
1013
PUT
PagSeguro Digital
PAGS
$2.62B
| $17M | 0.01% |
+646,600
| New | +$21M |
|
1014
Owens Corning
OC
$12.1B
| $16.9M | 0.01% |
187,110
-129,443
| -41% | -$11.7M |
|
|
HZNP
1015
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $16.9M | 0.01% |
156,908
-35,363
| -18% | -$3.86M |
|
1016
Boot Barn
BOOT
$4.97B
| $16.9M | 0.01% |
137,179
+61,342
| +81% | +$6.93M |
|
1017
EQT Corp
EQT
$32.3B
| $16.8M | 0.01% |
772,240
-745,060
| -49% | -$15.6M |
|
1018
Sinclair Inc
SBGI
$1.07B
| $16.8M | 0.01% |
635,790
+613,680
| +2,776% | +$16.4M |
|
1019
Digital Turbine
APPS
$1.73B
| $16.8M | 0.01% |
274,893
+132,474
| +93% | +$9.01M |
|
1020
Tapestry
TPR
$32.7B
| $16.7M | 0.01% |
410,115
-603,605
| -60% | -$24.8M |
|
1021
PUT
Delta Air Lines
DAL
$60.5B
| $16.6M | 0.01% |
425,900
+303,600
| +248% | +$12.2M |
|
1022
Varonis Systems
VRNS
$4.87B
| $16.5M | 0.01% |
338,544
+130,337
| +63% | +$7.42M |
|
1023
PUT
Avis
CAR
$4.89B
| $16.5M | 0.01% |
79,500
+8,400
| +12% | +$1.86M |
|
1024
Intellia Therapeutics
NTLA
$1.57B
| $16.4M | 0.01% |
138,759
+62,574
| +82% | +$7.84M |
|
|
TGP
1025
DELISTED
Teekay LNG Partners L.P.
TGP
| $16.4M | 0.01% |
968,931
+958,562
| +9,244% | +$16.3M |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.